Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation (original) (raw)

References

  1. Anidjar, S. & Kieffer, E. Pathogenesis of acquired aneurysms of the abdominal aorta. Ann. Vase. Surg. 6, 298–305 (1992).
    Article CAS Google Scholar
  2. Braverman, A.C. Penetrating atherosclerotic ulcers of the aorta. Curr. Opin. Cardiol. 9, 591–597 (1994).
    Article CAS Google Scholar
  3. Macsweeney, ST., Powell, J.T & Greenhalgh, R.M. Pathogenesis of abdominal aortic aneurysm. Br. J. Surg. 81, 935–941 (1994).
    Article CAS Google Scholar
  4. Halloran, B.C. & Baxter, B.T. Pathogenesis of aneurysms. Semin. Vase. Surg. 8, 85–92 (1995).
    CAS Google Scholar
  5. Patel, M.I., Hardman, D.T., Fisher, C.M. & Appleberg, M. Current views on the pathogenesis of abdominal aortic aneurysms. J. Am. Coll. Surg. 181, 371–382 (1995).
    CAS PubMed Google Scholar
  6. Libby, P. Molecular basis of the acute coronary syndromes. Circulation 91, 2844–2850 (1995).
    Article CAS Google Scholar
  7. Schneiderman, J. et al. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall: a possible mechanism for aneurysm expansion. J. Clin. Invest. 96, 639–645 (1995).
    Article CAS Google Scholar
  8. Newman, K.M. et al. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J. Vase. Surg. 20, 814–820 (1994).
    Article CAS Google Scholar
  9. Halpert, I. et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl. Acad, Sd. USA 93, 9748–9753 (1996).
    Article CAS Google Scholar
  10. Lupu, F. et al. Plasminogen activator expression in human atherosclerotic lesions. Arteriosder. Thromb. Vase. Biol. 15, 1444–1455 (1995).
    Article CAS Google Scholar
  11. Dollery, CM., McEwan, J.R., & Henney, A.M. Matrix metalloproteinases and cardiovascular disease. Ore. Res. 77, 863–868 (1995).
    CAS Google Scholar
  12. Galis, Z.S., Sukhova, G.K., Lark, M.W. & Libby, P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94, 2493–2503 (1994).
    Article CAS Google Scholar
  13. Murphy, G. Matrix metalloproteinases and their inhibitors. Acta Orthop. Scand. (Suppl. 256) 66, 55–60 (1995).
    Article Google Scholar
  14. Collen, D. & Lijnen, H.R. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 78, 3114–3124 (1991).
  15. Carmeliet, P. & Collen, D. Gene manipulation and transfer of the plasminogen system and coagulation system in mice. Semin. Thromb. Hemostasis 22, 525–542 (1996).
    Article CAS Google Scholar
  16. Murphy, G., Atkinson, S., Ward, R., Gavrilovic, J. & Reynolds, J.J. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann. NY Acad. Sd. 667, 1–12 (1992).
    Article CAS Google Scholar
  17. Eeckhout, Y. & Vaes, G. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Biochem. J. 166, 21–31 (1977).
    Article CAS Google Scholar
  18. Plump, A.S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353 (1992).
    Article CAS Google Scholar
  19. Carmeliet, P. et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419–424 (1994).
    Article CAS Google Scholar
  20. Johnston, K.W. et al. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J. Vase. Surg. 13, 452–458 (1991).
    Article CAS Google Scholar
  21. Shapiro, S.D., Kobayashi, D.K. & Ley, T.J. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 269, 23824–23829 (1993).
    Google Scholar
  22. Murphy, G., Cockett, M.D., Ward, R.V. & Docherty, A.J.P. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: a quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277, 277–279 (1991).
    Article CAS Google Scholar
  23. Werb, Z., Banda, M.J. & Jones, P.A. Degradation of connective tissue matrices by macrophages: I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages. J. Exp. Med. 152, 1340–1357 (1980).
    Article CAS Google Scholar
  24. Coussens, L.M. & Werb, Z. Matrix metalloproteinases and the development of cancer. Chem. Biol. 3, 895–904 (1996).
    Article CAS Google Scholar
  25. Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D. & Williams, R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68, 231–240 (1987).
    Article CAS Google Scholar
  26. Shipley, J.M., Wesselschmidt, R.L., Kobayashi, O.K., Ley, T.J. & Shapiro, S.D. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sd. USA 93, 3942–3946 (1996).
    Article CAS Google Scholar
  27. Carmeliet, P. et al. Urokinase-type but not tissue-type plasminogen activator mediates arterial neointima formation in mice. Circ. Res. 81, 829–839 (1997).
    Article CAS Google Scholar
  28. Delaisse, J. et al. (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J. Cell Sd. 106, 1071–1082 (1993).
  29. Senior, R.M., Connelly, N.L., Cury, J.D., Welgus, H.G. & Campbell, E.J. Elastin degradation by human alveolar macrophages: a prominent role of metalloproteinase activity. Am. Rev. Respir. Dis. 139, 1251–1256 (1989).
    Article CAS Google Scholar

Download references